​

Oruka Therapeutics (ORKA) Stock Forecast, Price Target & Predictions

OverviewChart

ORKA Stock Forecast

Oruka Therapeutics (ORKA) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $33.33, with a high of $40.00 and a low of $20.00. This represents a 209.76% increase from the last price of $10.76.

ORKA Stock Rating

Oruka Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

Price Target Trends

1M3M12M
# Anlaysts113
Avg Price Target$20.00$20.00$33.33
Last Closing Price$10.76$10.76$10.76
Upside/Downside85.87%85.87%209.76%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2517---8
Jan, 2516---7
Dec, 2416---7
Nov, 2436---9
Oct, 2436---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 04, 2025Andy ChenWolfe Research$20.00$13.7045.99%85.87%
Sep 12, 2024Michael YeeJefferies$40.00$26.0053.85%271.75%
Sep 04, 2024David NierengartenWedbush$40.00$25.5056.86%271.75%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 04, 2025Wolfe ResearchOutperforminitialise
Oct 07, 2024H.C. WainwrightBuyinitialise
Sep 25, 2024Cowen & Co.BuyBuyhold
Sep 16, 2024Cowen & Co.Buyinitialise
Sep 12, 2024JefferiesBuyinitialise
Sep 03, 2024WedbushOutperforminitialise

Financial Forecast

EPS Forecast

Reported
Avg Forecast
High Forecast
Low Forecast
Surprise %

Revenue Forecast

Reported
Avg Forecast
High Forecast
Low Forecast
Surprise %

Net Income Forecast

Reported
Avg Forecast
High Forecast
Low Forecast
Surprise %

ORKA Forecast FAQ

Is Oruka Therapeutics stock a buy?

Oruka Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Oruka Therapeutics is a favorable investment for most analysts.

What is Oruka Therapeutics's price target?

Oruka Therapeutics's price target, set by 5 Wall Street analysts, averages $33.33 over the next 12 months. The price target range spans from $20 at the low end to $40 at the high end, suggesting a potential 209.76% change from the previous closing price of $10.76.

How does Oruka Therapeutics stock forecast compare to its benchmarks?

Oruka Therapeutics's stock forecast shows a 209.76% upside.

What is the breakdown of analyst ratings for Oruka Therapeutics over the past three months?

  • February 2025: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.